Lv1
76 积分 2025-03-25 加入
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
12天前
已完结
Trends in the development of cellular and gene therapy in China
17天前
已完结
A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation
1个月前
已完结
Targeting KRAS in cancer
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2个月前
已完结
Transforming TGF-β suppression into IL-15 stimulation: Advancing engineered CAR-T therapy for solid tumors
2个月前
已完结
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
2个月前
已完结
皖公网安备34019202002308
